About EndoMed
EndoMed is a Healthcare company based in Delhi (India) by Kanwar Sehgal. It manufactures endoscopic tools for GI, bronchoscopy, and laparoscopy procedures. It operates on a B2B and Distributor-based Sales model. Its Indian entity Endo-Med Technologies Private Limited reported revenue of ₹6.08 Cr. EndoMed offers products and services including Biopsy Forceps, Metal Stents, Foreign Body Forceps, Drainage Catheters, and Extraction Basket. Its focus areas include Medical Devices, Endoscopy, GI Endoscopy and Surgical Instruments.
Company details
Endomed Technologies Pvt. Ltd. designs and produces medical devices such as biopsy forceps, stents, and drainage catheters for endoscopy, bronchoscopy, and laparoscopy. They operate through manufacturing and distribution networks, serving healthcare providers via medical fairs and distributors. Based in India, they focus on quality instruments for surgical applications, including stone management and foreign body removal, to support global medical needs.
- Headquarters Delhi, India
- Founders Kanwar Sehgal
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website endomed.in
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Endo-Med Technologies Private Limited
- Date of Incorporation 06 Sep, 2006
- Jurisdiction Delhi, India
- Annual Revenue₹6.08 Cr
FY 2024 · +28% YoY
- Net Profit₹18.2 Lakh
FY 2024 · 3% margin
- EBITDA₹72 Lakh
FY 2024 · 12% margin
Associated legal entities of EndoMed
EndoMed operates through Endo-Med Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Endo-Med Technologies Private Limited CIN U85121DL2006PTC153175 | Active | 06 Sep 2006 | Delhi, Delhi | ₹6.1 Cr | – | 2 | View details |
Products & Services of EndoMed
EndoMed offers a comprehensive portfolio of products and services, including Biopsy Forceps, Metal Stents, Foreign Body Forceps, Drainage Catheters, and Extraction Basket.
Instruments for tissue sampling in gastrointestinal procedures
Devices to maintain open passages in medical applications
Tools for removing objects from body passages
Catheters for fluid management in surgeries
Device for retrieving items during procedures
Apps and channels of EndoMed
its YouTube channel Endo-Med Technologies Pvt. Ltd. has 122 subscribers and 7 videos.
Videos from EndoMed
The most watched videos on EndoMed's YouTube channel, Endo-Med Technologies Pvt. Ltd. (122 subscribers). Click a video to play it here.
More on Endo-Med Technologies Pvt. Ltd..
Board of directors of Endo-Med Technologies Private Limited (EndoMed)
Endo-Med Technologies Private Limited is the primary company behind EndoMed. The board of Endo-Med Technologies Private Limited currently have 2 directors; the longest-serving is Geeta Sehgal, appointed in 2006.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Geeta Sehgal DIN 00271000 | Director | 06 Sep 2006 | 20 yrs 1 mo | Endo-Med Technologies Private Limited |
| Kanwar Sehgal DIN 00270963 | Director | 06 Sep 2006 | 20 yrs 1 mo | Endo-Med Technologies Private Limited |
People of EndoMed
1 people are tracked at EndoMed (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, Director | Leadership |
Complete people profiles for EndoMed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of EndoMed
Figures of Endo-Med Technologies Private Limited, the primary company behind EndoMed, for FY 2024. Revenue was ₹6.08 Cr (+28% year on year). Net profit was ₹18.2 Lakh (3% margin). EBITDA was ₹72 Lakh (12% margin). Revenue has grown at a compounded annual rate of +49% over three years and +37% over five years.
- ₹6.08 CrRevenue · FY 2024 · +28% YoY
- ₹18.2 LakhNet profit · 3% margin
- ₹72 LakhEBITDA · 12% margin
- ₹20 LakhPaid-up capital
- +49%Revenue CAGR, 3 years
- +37%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Endo-Med Technologies Private Limited are on its company page.
Detailed financial statements for EndoMed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of EndoMed
The website of EndoMed (endomed.in) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 11.5% vs previous month
Top companies in Gastroenterology
10 companies that operate in the same segment as EndoMed (Gastroenterology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Implantable battery-powered pumps for ascites removal are developed. | 2006 | Zurich, Switzerland | USD 35.5 M | – | – | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | – | – | |
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | – | 411 | |
Developer of electrosurgical system and range of flexible endoscopic instruments | 2003 | Chepstow, Monmouthshire, United Kingdom | USD 20.84 M | USD 8.08 M | 141 | |
Non-invasive biomarker tests for colorectal cancer are developed. | 2015 | St. Louis, Missouri, United States | USD 218.95 M | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed. | 2007 | Fremont, California, United States | USD 61.1 M | USD 407.32 M | 395 | |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases | 2009 | Ramat Gan, Tel Aviv District, Israel | USD 13.5 M | USD 288.27 K | 35 | |
Biologics are developed for cardio-metabolic and liver diseases. | 2007 | San Francisco, California, United States | USD 358.87 M | USD 330.53 M | 71 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EndoMed
EndoMed is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind EndoMed, Endo-Med Technologies Private Limited, reported revenue of ₹6.08 Cr for FY 2024, up 28% year on year.
Endomed Technologies Pvt. Ltd. designs and produces medical devices such as biopsy forceps, stents, and drainage catheters for endoscopy, bronchoscopy, and laparoscopy. They operate through manufacturing and distribution networks, serving healthcare providers via medical fairs and distributors. Based in India, they focus on quality instruments for surgical applications, including stone management and foreign body removal, to support global medical needs.
EndoMed offers Biopsy Forceps, Metal Stents, Foreign Body Forceps, Drainage Catheters, and Extraction Basket.
EndoMed operates through Endo-Med Technologies Private Limited.
The legal entities of EndoMed currently have 2 directors, including Geeta Sehgal, Kanwar Sehgal.